Literature DB >> 25232261

Smoking increases the risk of extraintestinal manifestations in Crohn's disease.

Claudia Ott1, Angela Takses1, Florian Obermeier1, Elisabeth Schnoy1, Martina Müller1.   

Abstract

AIM: To demonstrate a high prevalence of extraintestinal manifestations (EIMs) in a prospective population-based cohort of inflammatory bowel disease (IBD) patients at first diagnosis as well as during the early course of the disease.
METHODS: EIMs are common in patients with IBD. Data on the frequency of EIMs have mostly been assessed in patients from tertiary centers; however, data about the prevalence of EIMs at first diagnosis as well as factors influencing their incidence during the early course of disease from prospective population-based cohorts are scarce. We present data of patients of our population-based "Oberpfalz cohort" (Bavaria, Germany) from first diagnosis (up to 3 mo after first diagnosis) as well as during the early course of the disease. Possible risk factors were assessed by calculating the relative risk (RR) as well as using logistic regression analysis.
RESULTS: In total, data of 257 newly diagnosed patients with IBD were evaluated [161 Crohn's disease (CD), 96 ulcerative colitis (UC)]. Median duration of follow-up was 50 mo after first diagnosis. In 63.4% of all patients (n = 163), an EIM was diagnosed at any point during the observation period. At first diagnosis, patients with CD had a significantly increased risk of an EIM [n = 69 (42.9%)] compared with UC patients [n = 21 (21.9%); P < 0.001; RR = 1.96; 95%CI: 1.30-2.98]. Active smoking increased the risk of CD patients developing an EIM during the early course of the disease, but notably not of UC patients (P = 0.046; RR = 1.96; 95%CI: 1.01-3.79). In addition, using logistic regression analysis, the need for IBD-related surgery and a young age at first diagnosis were identified as risk factors for the development of an EIM in CD patients. No association with EIMs was found for the factors sex, localization of the disease and positive family history of IBD. In contrast, no key factors which increased the risk of development of an EIM could be identified in UC patients.
CONCLUSION: We found a high prevalence of EIM in this cohort at first diagnosis and during the early course of the disease. In patients with CD, smoking, need for surgery and younger age at first diagnosis were risk factors for the development of an EIM.

Entities:  

Keywords:  Age at onset; Crohn’s disease; Extraintestinal manifestations; Smoking; Surgery; Ulcerative colitis

Mesh:

Year:  2014        PMID: 25232261      PMCID: PMC4161812          DOI: 10.3748/wjg.v20.i34.12269

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study).

Authors:  Oyvind Palm; Bjørn Moum; Aksel Ongre; Jan Tore Gran
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

Review 2.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Chinyu G Su; Thomas A Judge; Gary R Lichtenstein
Journal:  Gastroenterol Clin North Am       Date:  2002-03       Impact factor: 3.806

Review 3.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

Review 4.  Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?

Authors:  Fernando Tavarela Veloso
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

5.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

6.  Effects of current and former cigarette smoking on the clinical course of Crohn's disease.

Authors:  J Cosnes; F Carbonnel; F Carrat; L Beaugerie; S Cattan; J Gendre
Journal:  Aliment Pharmacol Ther       Date:  1999-11       Impact factor: 8.171

7.  Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: results from CARE.

Authors:  Robert Löfberg; Edouard V Louis; Walter Reinisch; Anne M Robinson; Martina Kron; Anne Camez; Paul F Pollack
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

8.  Cutaneous manifestations in inflammatory bowel disease.

Authors:  A Tromm; D May; E Almus; E Voigt; I Greving; U Schwegler; T Griga
Journal:  Z Gastroenterol       Date:  2001-02       Impact factor: 2.000

9.  Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease.

Authors:  Michael F Picco; Theodore M Bayless
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

10.  Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients.

Authors:  C Salvarani; I G Vlachonikolis; D M van der Heijde; G Fornaciari; P Macchioni; M Beltrami; I Olivieri; F Di Gennaro; P Politi; R W Stockbrügger; M G Russel
Journal:  Scand J Gastroenterol       Date:  2001-12       Impact factor: 2.423

View more
  12 in total

1.  Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Authors:  M Severs; S J H van Erp; M E van der Valk; M J J Mangen; H H Fidder; M van der Have; A A van Bodegraven; D J de Jong; C J van der Woude; M J L Romberg-Camps; C H M Clemens; J M Jansen; P C van de Meeberg; N Mahmmod; C Y Ponsioen; C Bolwerk; J R Vermeijden; M J Pierik; P D Siersema; M Leenders; A E van der Meulen-de Jong; G Dijkstra; B Oldenburg
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

2.  Original Research: Extract of Bambusae Caulis in Taeniam inhibits cigarette smoke-induced pulmonary and intestinal inflammation.

Authors:  Dahae Lim; Youngwoo Cho; Woogyeong Kim; Sehee Jeong; Young Pyo Jang; Jinju Kim
Journal:  Exp Biol Med (Maywood)       Date:  2016-09-02

Review 3.  Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors:  Jason S Reich; Francis A Farraye; Sharmeel K Wasan
Journal:  Dig Dis Sci       Date:  2016-04-09       Impact factor: 3.199

Review 4.  Influence of environmental factors on the onset and course of inflammatory bowel disease.

Authors:  Amit Kumar Dutta; Ashok Chacko
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

5.  Multiple Enteroenteric Fistulas- Crohn's Disease- A Case Report.

Authors:  Hasnain Abbas Dharamshi; Ali Abbas Mohsin Ali; Tufail Raza; Narmeen Shahid; Faizan Sheraz; Tooba Sajid; Zohair Lilani; Mustaqueem Ur Rehman; Taha Nafees
Journal:  Iran J Public Health       Date:  2015-11       Impact factor: 1.429

Review 6.  Care of inflammatory bowel disease patients in remission.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-10-10

7.  Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease.

Authors:  Lieke M Spekhorst; Floris Imhann; Eleonora A M Festen; Ad A van Bodegraven; Nanne K H de Boer; Gerd Bouma; Herma H Fidder; Geert d'Haens; Frank Hoentjen; Daan W Hommes; Dirk J de Jong; Mark Löwenberg; P W Jeroen Maljaars; Andrea E van der Meulen-de Jong; Bas Oldenburg; Marieke J Pierik; Cyriel Y Ponsioen; Pieter C Stokkers; Hein W Verspaget; Marijn C Visschedijk; C Janneke van der Woude; Gerard Dijkstra; Rinse K Weersma
Journal:  BMJ Open       Date:  2017-11-08       Impact factor: 2.692

8.  Pulmonary dysfunction in 114 patients with inflammatory bowel disease.

Authors:  Yujie Zhao; Junshan Wang; Zhanju Liu; Hui Lin; Yanhong Shi; Xiaomin Sun
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

9.  The Effect of Cigarette Smoke Exposure on the Development of Inflammation in Lungs, Gut and Joints of TNFΔARE Mice.

Authors:  Liesbeth Allais; Smitha Kumar; Karlijn Debusschere; Stephanie Verschuere; Tania Maes; Rebecca De Smet; Griet Conickx; Martine De Vos; Debby Laukens; Guy F Joos; Guy G Brusselle; Dirk Elewaut; Claude A Cuvelier; Ken R Bracke
Journal:  PLoS One       Date:  2015-11-02       Impact factor: 3.240

Review 10.  Risk factors for postoperative recurrence of Crohn's disease with emphasis on surgical predictors.

Authors:  Antonios Gklavas; Dionysios Dellaportas; Ioannis Papaconstantinou
Journal:  Ann Gastroenterol       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.